Skip to main content
Back
Watch Compare

PSYCHEMEDICS CORP

Data quality: 83%
PMDI
OTC Services Health Services
$1.80
▼ $0.22 (-10.89%)
Mkt Cap: 12.34 M
Price
$2.02
Mkt Cap
12.34 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Generating 878,000.0 in free cash flow

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)-56.79%

Quality

Return on Equity
-33.27%
Below sector avg (-15.95%)
ROIC-24.11%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio1.59
Interest Coverage-72.81

Valuation

PE (TTM)
-6.63
Below sector avg (-1.17)
P/B Ratio2.27
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -6.6 -1.2
P/B 2.3 1.4
ROE % -33.3 -16.0
Net Margin % — -19.4
Rev Growth 5Y % — 4.0
D/E — 0.4

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42014 $0.08 $0.13 +62.5%
Q32014 $0.12 $0.17 +41.7%
Q22014 $0.03 $0.16 +433.3%
Q12014 $0.12 $0.15 +25.0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -1.86 M
ROE -33.27% ROA -18.66%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 878,000.0
ROIC -24.11% FCF Growth (3Y) -56.79%
Safety
Debt / Equity N/A Current Ratio 1.59
Interest Coverage -72.81 Asset Turnover N/A
Working Capital 2.25 M Tangible Book Value 5.45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.63 Forward P/E N/A
P/B Ratio 2.27 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 7.11%
Market Cap 12.34 M Enterprise Value 10.94 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0.14 OCF / Share 0.15
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -47.18%
SBC-Adj. FCF -347,000 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -1.86 M -4.15 M -1.08 M -665,000.0 -3.86 M
EPS (Diluted) — — -0.19 -0.12 -0.70
Gross Profit 7.10 M 8.41 M 9.29 M 10.26 M 4.89 M
Operating Income -1.89 M -2.92 M -1.08 M 209,000.0 -6.07 M
EBITDA — — — — —
R&D Expenses 749,000.0 1.14 M 1.33 M 1.13 M 1.28 M
SG&A Expenses — — — — —
D&A 1.10 M 1.70 M 2.40 M 2.70 M 2.60 M
Interest Expense 26,000.0 17,000.0 32,000.0 49,000.0 75,000.0
Income Tax -55,000.0 716,000.0 44,000.0 -156,000.0 -2.35 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 8.32 M 12.33 M 18.73 M 21.55 M 24.00 M
Total Liabilities 3.19 M 5.65 M 7.96 M 9.31 M 11.49 M
Shareholders' Equity 5.13 M 6.67 M 10.77 M 12.24 M 12.51 M
Total Debt — 0.0 305,000.0 599,000.0 3.44 M
Cash & Equivalents 1.42 M 1.96 M 4.75 M 1.99 M 2.83 M
Current Assets 4.94 M 6.81 M 9.96 M 10.29 M 9.60 M
Current Liabilities 2.71 M 4.71 M 5.72 M 5.83 M 3.94 M